JGA Suspends Taiyo Pharmaceutical Membership
This article was originally published in PharmAsia News
Executive SummaryThe Japan Generic Association March 29 announced it would suspend Taiyo Pharmaceutical membership for one year because of a manufactuirng violation uncovered in March
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.